SCNI

2.20

2.33% 0.05

Handel nachbörslich: 2.15 -0.05 -2.27%

Scinai Immunotherapeutics Ltd Adr (SCNI)

Überblick Nachrichten Preisverlauf Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$2.15

Offen:

$2.12

24-Stunden-Volumen:

34,685

Relative Volume:

0.09

Marktkapitalisierung:

$2.20M

Einnahmen:

Nettoeinkommen (Verlust:

$-9.29M

KGV:

-0.4231

EPS:

-5.2

Netto-Cashflow:

$-9.42M

1W Leistung:

-4.35%

1M Leistung:

-0.63%

6M Leistung:

-38.20%

1J Leistung:

-49.89%

1-Tages-Spanne:

$2.12

$2.20

1-Wochen-Bereich:

$2.10

$2.35

52-Wochen-Spanne:

$1.90

$6.18

Scinai Immunotherapeutics Ltd Adr Stock (SCNI) Company Profile

Firmenname

Scinai Immunotherapeutics Ltd Adr

Sektor

Healthcare (1161)

Branche

Biotechnology (654)

Telefon

972-8-9302529

Adresse

JERUSALEM BIOPARK, 2ND FLOOR, JERUSALEM

Mitarbeiter

Twitter

Nächster Verdiensttermin

Neueste SEC-Einreichungen

SCNI's Discussions on Twitter

Vergleichen Sie SCNI mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
SCNI Scinai Immunotherapeutics Ltd Adr	2.20	2.30M	0	-9.29M	-9.42M	-5.20
VRTX Vertex Pharmaceuticals Inc	458.49	121.30B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	545.53	61.60B	14.09B	4.50B	2.96B	39.28
ALNY Alnylam Pharmaceuticals Inc	320.52	41.17B	2.35B	-269.70M	-75.39M	-2.09
ARGX Argen X Se Adr	566.14	34.35B	2.58B	1.06B	-1.28B	16.33
ONC Beone Medicines Ltd Adr	291.93	27.29B	3.81B	-644.79M	-669.77M	-6.24

Scinai Immunotherapeutics Ltd Adr Aktie (SCNI) Neueste Nachrichten

Jun 19, 2025

Augusta Gold (TSE:G) Shares Pass Below Two Hundred Day Moving Average – Time to Sell? - Defense World

Jun 19, 2025

Jun 04, 2025

Scinai Immunotherapeutics Faces Financial Challenges, Seeks Growth - TipRanks

Jun 04, 2025

Jun 02, 2025

Scinai Immunotherapeutics Reports Strong CDMO Growth - TipRanks

Jun 02, 2025

May 09, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Expands CDMO Operations with New U.S. Subsidiary - Barchart.com

May 09, 2025

May 08, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Reports $4.8M Net Gain in 2024, Driven by Loan-to-Equity Conversion - Barchart.com

May 08, 2025

May 01, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) to Host Webinar on PC111 Antibody for Rare Skin Disorders - Barchart.com

May 01, 2025

Apr 01, 2025

Military Breakthrough: BrainChip and Raytheon Land $1.8M Air Force Deal for Next-Gen Radar - Stock Titan

Apr 01, 2025

Mar 05, 2025

Scinai Immunotherapeutics (NASDAQ: SCNI) Enters $10M Standby Equity Purchase Agreement - Barchart

Mar 05, 2025

Feb 07, 2025